Barry A. Rosenzweig

3.4k citations

28 papers · 921 indexed · h-index 16

Nephrology top 5%
Cancer Research top 10%
- MicroRNA in disease regulation 2
Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 3
Health, Toxicology and Mutagenesis top 10%
Molecular Biology
- Molecular Biology Techniques and Applications 5
- Gene expression and cancer classification 4
- DNA Repair Mechanisms 3
Immunology
- interferon and immune responses 2
Physiology
- Lysosomal Storage Disorders Research 2
Surgery
- Pancreatitis Pathology and Treatment 2

Co-authors: Karol L. Thompson Frank D. Sistare Vishal S. Vaidya Joseph V. BonventreJun ZhangYuzhao Zhou Peter L. Goering Ronald P. Brown
Cited by: Nephrology Cancer Research Pharmacology
Journals: PLoS ONE (1 paper)The FASEB Journal (1 paper)Environmental Health Perspectives (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Barry A. Rosenzweig

28 papers receiving 891 citations

Peers

Countries citing papers authored by Barry A. Rosenzweig

Since Specialization

Citations

This map shows the geographic impact of Barry A. Rosenzweig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry A. Rosenzweig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry A. Rosenzweig more than expected).

Fields of papers citing papers by Barry A. Rosenzweig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry A. Rosenzweig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry A. Rosenzweig. The network helps show where Barry A. Rosenzweig may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Barry A. Rosenzweig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barry A. Rosenzweig Line = papers co-authored together Barry A. Rosenzweig links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluating the Utility of Proteomics for the Identification of Circulating Pharmacodynamic Biomarkers of IFNβ‐1a Biologics Clinical Pharmacology & Therapeutics ·Paula L. Hyland,Lakshmi Manasa S. Chekka,Deepti P. Samarth,Barry A. Rosenzweig,Erica Decker,Esraa G. Mohamed,Yan Guo,Murali K. Matta,Qin Sun,William Wheeler,Carlos Sanabria,James L. Weaver,Sarah J. Schrieber,Jeffry Florian,Yow‐Ming Wang,David G. Strauss	2022	3
2	Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation Clinical and Translational Science ·Andrés M. Rubiano,Amruta Indapurkar,Ryosuke Yokosawa,Alina Miedzik,Barry A. Rosenzweig,Ayesha Arefin,Chloe Moulin,Keri Dame,Neil R. Hartman,Donna A. Volpe,Murali K. Matta,David Hughes,David G. Strauss,Tomasz Kostrzewski,Alexandre J. S. Ribeiro	2020	68
3	Quantitation of residual host cell DNA in protaminesulfate drug product by qPCR Journal of Pharmaceutical and Biomedical Analysis ·Cynthia D. Sommers,Barry A. Rosenzweig,Lida Oum,Karol L. Thompson,David A. Keire	2018	3
4	MicroRNA biomarkers of pancreatic injury in a canine model Experimental and Toxicologic Pathology ·Rodney Rouse,Barry A. Rosenzweig,Katie Shea,Alan Knapton,Sharron Stewart,Lin Xu,Ashok Chockalingam,Leah M. Zadrozny,Karol L. Thompson	2016	23
5	Extended Exenatide Administration Enhances Lipid Metabolism and Exacerbates Pancreatic Injury in Mice on a High Fat, High Carbohydrate Diet PLoS ONE ·Rodney Rouse,Leshuai W. Zhang,Katherine Shea,Hongfei Zhou,Lin Xu,Sharron Stewart,Barry A. Rosenzweig,Jun Zhang	2014	8
6	Evaluation of miR-216a and miR-217 as potential biomarkers of acute pancreatic injury in rats and mice Biomarkers ·David G. Goodwin,Barry A. Rosenzweig,Jun Zhang,Lin Xu,Sharron Stewart,Karol L. Thompson,Rodney Rouse	2014	40
7	Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats Toxicology Letters ·Karol L. Thompson,Jun Zhang,Sharron Stewart,Barry A. Rosenzweig,Katherine Shea,Daniel J. Mans,Thomas Colatsky	2012	11
8	An adaptable method using human mixed tissue ratiometric controls for benchmarking performance on gene expression microarrays in clinical laboratories BMC Biotechnology ·P. Scott Pine,Barry A. Rosenzweig,Karol L. Thompson	2011	8
9	A Multifaceted Evaluation of Imatinib-induced Cardiotoxicity in the Rat Toxicologic Pathology ·Eugene H. Herman,Alan Knapton,Elliot T. Rosen,Karol L. Thompson,Barry A. Rosenzweig,Joel Estis,Sara J. Agee,Quynh-Anh Lu,John A. Todd,Steven E. Lipshultz,Brian B. Hasinoff,Jun Zhang	2011	49
10	Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats Kidney International ·Rodney Rouse,Jun Zhang,Sharron Stewart,Barry A. Rosenzweig,Parvaneh Espandiari,Nakissa Sadrieh	2010	53
11	Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats Cancer Chemotherapy and Pharmacology ·Karol L. Thompson,Barry A. Rosenzweig,Jun Zhang,Alan Knapton,Ronald Honchel,Steven E. Lipshultz,Jacques Retief,Frank D. Sistare,Eugene H. Herman	2009	51
12	The Utility of a Rodent Model in Detecting Pediatric Drug-Induced Nephrotoxicity Toxicological Sciences ·Parvaneh Espandiari,Jun Zhang,Barry A. Rosenzweig,Vishal S. Vaidya,Jinchun Sun,Laura K. Schnackenberg,Eugene H. Herman,Alan Knapton,Joseph V. Bonventre,Richard D. Beger,Karol L. Thompson,Joseph P. Hanig	2007	36
13	Characterization of the effect of sample quality on high density oligonucleotide microarray data using progressively degraded rat liver RNA BMC Biotechnology ·Karol L. Thompson,P. Scott Pine,Barry A. Rosenzweig,Yaron Turpaz,Jacques Retief	2007	68
14	Comparison of Kidney Injury Molecule-1 and Other Nephrotoxicity Biomarkers in Urine and Kidney Following Acute Exposure to Gentamicin, Mercury, and Chromium Toxicological Sciences ·Yuzhao Zhou,Vishal S. Vaidya,Ronald P. Brown,Jun Zhang,Barry A. Rosenzweig,Karol L. Thompson,Terry J. Miller,Joseph V. Bonventre,Peter L. Goering	2007	231
15	Alterations in gene expression profiles and the DNA‐damage response in ionizing radiation‐exposed TK6 cells Environmental and Molecular Mutagenesis ·Gregory Akerman,Barry A. Rosenzweig,Olen E. Domon,Chen‐An Tsai,Michelle E. Bishop,Lynda J. McGarrity,James T. MacGregor,Frank D. Sistare,James J. Chen,Suzanne M. Morris	2005	47
16	Dye Bias Correction in Dual-labeled cDNA Microarray Gene Expression Measurements Environmental Health Perspectives ·Barry A. Rosenzweig,P. Scott Pine,Olen E. Domon,Suzanne M. Morris,James J. Chen,Frank D. Sistare	2004	3
17	Dye bias correction in dual-labeled cDNA microarray gene expression measurements. Environmental Health Perspectives ·Barry A. Rosenzweig,P. Scott Pine,Olen E. Domon,Suzanne M. Morris,James J. Chen,Frank D. Sistare	2004	57
18	Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene‐derived mRNA† Molecular Carcinogenesis ·Karol L. Thompson,Barry A. Rosenzweig,Ronald Honchel,Ronald E. Cannon,Kerry T. Blanchard,Raymond E. Stoll,Frank D. Sistare	2001	9
19	An Evaluation of the Hemizygous Transgenic Tg.AC Mouse for Carcinogenicity Testing of Pharmaceuticals. I. Evidence for a Confounding Nonresponder Phenotype Toxicologic Pathology ·James L. Weaver,Joseph F. Contrera,Barry A. Rosenzweig,Karol L. Thompson,Patrick J. Faustino,John M. Strong,Christopher D. Ellison,Lawrence W. Anderson,H. R. Prasanna,Patricia E. Long-Bradley,Karl K. Lin,Jun Zhang,Frank D. Sistare	1998	23
20	Interactions of Thyrotropin-Releasing Hormone, Phorbol Ester, and Forskolin-Sensitive Regions of the Rat Thyrotropin-β Gene Molecular Endocrinology ·Margaret A. Shupnik,Barry A. Rosenzweig,Mark O. Showers	1990	24

About Barry A. Rosenzweig

Barry A. Rosenzweig is a scholar working on Pharmacology, Nephrology and Cancer Research, having authored 28 papers that have together received 921 indexed citations. Recurring topics across this work include Molecular Biology Techniques and Applications (5 papers), Gene expression and cancer classification (4 papers), DNA Repair Mechanisms (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), interferon and immune responses (2 papers), MicroRNA in disease regulation (2 papers), Lysosomal Storage Disorders Research (2 papers) and Pancreatitis Pathology and Treatment (2 papers). The work is most often cited by research in Nephrology (162 citations), Cancer Research (163 citations) and Pharmacology (73 citations). Barry A. Rosenzweig has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Karol L. Thompson, Frank D. Sistare, Vishal S. Vaidya, Joseph V. Bonventre, Jun Zhang, Yuzhao Zhou, Peter L. Goering, Ronald P. Brown, Terry J. Miller and P. Scott Pine. Their work appears in journals such as PLoS ONE, The FASEB Journal and Environmental Health Perspectives.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact